📣 VC round data is live. Check it out!

SC Ropharma Valuation Multiples

Discover revenue and EBITDA valuation multiples for SC Ropharma and similar public comparables like Farmacosmo, Pilulka Lekarny, Rise, PetMeds and more.

SC Ropharma Overview

About SC Ropharma

SC Ropharma SA is engaged in the production, distribution, and Retail sale of pharmaceutical products in specialized stores. Its product portfolio comprises over 50 products in the form of tablets, powders, capsules, and syrups covering 21 therapeutic areas.


Founded

1952

HQ

Romania

Employees

1.3K

Sectors

Financials (FY)

Revenue: $265M
EBITDA: $12M

EV

$55M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

SC Ropharma Financials

SC Ropharma reported last fiscal year revenue of $265M and EBITDA of $12M.

In the same fiscal year, SC Ropharma generated $37M in gross profit, $12M in EBITDA, and had net loss of ($383K).


SC Ropharma P&L

In the most recent fiscal year, SC Ropharma reported revenue of $265M and EBITDA of $12M.

SC Ropharma is unprofitable as of last fiscal year, with gross margin of 14%, EBITDA margin of 5%, and net margin of (0%).

See analyst estimates for SC Ropharma
Last FY20232024202620272028
Revenue$265M$224M$265M
Gross Profit$37M$32M$37M
Gross Margin14%14%14%
EBITDA$12M$10M$12M
EBITDA Margin5%5%5%
EBIT Margin2%2%2%
Net Profit($383K)$2M($383K)
Net Margin(0%)1%(0%)
Net Debt$11M

Financial data powered by Morningstar, Inc.

SC Ropharma Stock Performance

SC Ropharma has current market cap of $23M, and enterprise value of $55M.

Market Cap Evolution


SC Ropharma's stock price is $0.04.

SC Ropharma share price decreased by 4.1% in the last 30 days, and increased by 19.9% in the last year.

See more trading valuation data for SC Ropharma
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$55M$23M1.1%-4.1%-8.0%19.9%$-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

SC Ropharma Valuation Multiples

SC Ropharma trades at 0.2x EV/Revenue multiple, and 4.4x EV/EBITDA.

See NTM and 2027E valuation multiples for SC Ropharma

SC Ropharma Financial Valuation Multiples

As of May 26, 2026, SC Ropharma has market cap of $23M and EV of $55M.

SC Ropharma has a P/E ratio of (59.8x).

Last FY20232024202620272028
EV/Revenue0.2x0.2x0.2x
EV/EBITDA4.4x5.4x4.4x
EV/EBIT8.9x13.6x8.9x
EV/Gross Profit1.5x1.7x1.5x
P/E(59.8x)13.4x(59.8x)
EV/FCF10.1x10.1x10.1x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified SC Ropharma Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

SC Ropharma Margins & Growth Rates

In the most recent fiscal year, SC Ropharma reported gross margin of 14%, EBITDA margin of 5%, and net margin of (0%).

See estimated margins and future growth rates for SC Ropharma

SC Ropharma Margins

Last FY2024202720282029
Gross Margin14%14%
EBITDA Margin5%5%
EBIT Margin2%2%
Net Margin(0%)(0%)
FCF Margin2%2%

SC Ropharma Growth Rates

23/2426/2727/2828/29
Revenue Growth18%
Gross Profit Growth15%
EBITDA Growth22%
EBIT Growth53%
Net Profit Growth(122%)
FCF Growth0%

Data powered by FactSet, Inc. and Morningstar, Inc.

SC Ropharma Operational KPIs

SC Ropharma's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for SC Ropharma
Last FY20232024202620272028
Revenue per Employee$0.2M
Opex per Employee$0.0M
G&A Expenses to Revenue0%0%0%
Opex to Revenue12%13%12%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

SC Ropharma Competitors

SC Ropharma competitors include Farmacosmo, Pilulka Lekarny, Rise, PetMeds, Talea Group, BlueMTec, d1000, MARX Biotech, Green Cross Health and Profarma.

Most SC Ropharma public comparables operate across Pharmacies.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Farmacosmo0.3x23.8x
Pilulka Lekarny0.3x(8.1x)
Rise5.1x4.5x18.7x
PetMeds0.1x0.1x2.9x(0.5x)
Talea Group0.6x24.4x
BlueMTec0.6x92.0x
d10000.3x3.8x
MARX Biotech5.1x35.6x

This data is available for Pro users. Sign up to see all SC Ropharma competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About SC Ropharma

When was SC Ropharma founded?SC Ropharma was founded in 1952.
Where is SC Ropharma headquartered?SC Ropharma is headquartered in Romania.
How many employees does SC Ropharma have?As of today, SC Ropharma has over 1K employees.
Is SC Ropharma publicly listed?Yes, SC Ropharma is a public company listed on Bucharest Stock Exchange.
What is the stock symbol of SC Ropharma?SC Ropharma trades under RPH ticker.
When did SC Ropharma go public?SC Ropharma went public in 1997.
Who are competitors of SC Ropharma?SC Ropharma main competitors include Farmacosmo, Pilulka Lekarny, Rise, PetMeds, Talea Group, BlueMTec, d1000, MARX Biotech, Green Cross Health, Profarma.
What is the current market cap of SC Ropharma?SC Ropharma's current market cap is $23M.
What is the current revenue of SC Ropharma?SC Ropharma's last fiscal year revenue is $265M.
What is the current EV/Revenue multiple of SC Ropharma?Current revenue multiple of SC Ropharma is 0.2x.
Is SC Ropharma profitable?No, SC Ropharma is not profitable.
How many companies SC Ropharma has acquired to date?SC Ropharma hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies SC Ropharma has invested to date?SC Ropharma hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to SC Ropharma

Lists including SC Ropharma

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial